Therapeutic burden in interstitial lung disease: Lessons to learn.
Yet Hong KhorIan N GlaspoleNicole Soo Leng GohPublished in: Respirology (Carlton, Vic.) (2019)
Polypharmacy and complex medication regimen are common in patients with ILD of different aetiologies. There is a high frequency of potential drug-disease interactions among patients who are prescribed systemic corticosteroids. These findings highlight the need for careful evaluation of the impact of therapeutic complexity and burden in patients with ILD.